• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2300180 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-10-26 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB2200145 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-08-08 Bayer Healthcare LLC view
JYSB2400158 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 Pfizer Europe Ma Eeig;Wyeth Farma SA view
CYSB2200011 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2022-01-10 SinoCelltech Ltd view
JYSB2200094 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2022-06-09 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2500082 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2025-03-26 Bayer Healthcare LLC view
JXSS2200002 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.1) Import Drug Application 2022-01-26 Octapharma Ab Sweden;Sichuan Sinco Pharmaceutical Co Ltd view
CXSB2400122 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) Supplementary Application 2024-10-13 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB2101027 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-05-12 Bayer Healthcare LLC view
JYSB2300034 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2023-02-23 Bayer Healthcare LLC view
JYSB2101161 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-10 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB1200214 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2012-08-27 拜耳医药保健有限公司 Bayer Healthcare Company Ltd;Bayer Healthcare LLC Approval Completed-Pending Certificated view
JYSB2400050 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-07 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB2101172 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JTS2200033 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Disposable Import Drug Application 2022-05-28 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd view
CYSB2400087 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-04-09 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB2101169 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JYSB2400249 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-12-04 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG view
JYSB2101170 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2021-11-25 Pfizer Europe Ma Eeig;Wyeth Farma SA view
JTS2200019 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Disposable Import Drug Application 2022-04-20 Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG;Takeda (China) International Trading Co Ltd view